Combivent (Ipratropium Bromide / Albuterol Sulfate) - Summary

COMBIVENT SUMMARY

Combivent® Inhalation Aerosol is a combination of ipratropium bromide and albuterol sulfate.

Combivent Inhalation Aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.

COMBIVENT NEWS HIGHLIGHTS

Media Articles Related to Combivent (Ipratropium / Albuterol)

Phase III Clinical Studies Of Aclidinium Bromide Show Statistical Significance Vs. Placebo In Patients With Chronic Obstructive Pulmonary Disease
Source: Respiratory / Asthma News From Medical News Today [2008.09.04]

Florida Is State With Highest Percentage Of Untreated Patients With Chronic Obstructive Pulmonary Disease
Source: Respiratory / Asthma News From Medical News Today [2008.08.30]

Chronic Obstructive Pulmonary Disease And Home Rehabilitation - The Mobile Phone's Crucial Role
Source: IT / Internet / E-mail News From Medical News Today [2008.08.29]

Chronic Obstructive Pulmonary Disease
Source: MedicineNet Alpha 1 Antitrypsin Deficiency Specialty [2006.10.13]

Lung's Protective Response Against Tobacco Smoke Blocked By Infection
Source: Smoking / Quit Smoking News From Medical News Today [2008.08.21]

more>>

Published Studies Related to Combivent (Ipratropium / Albuterol)

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]

Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. [1997.08]

The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. [1997.02]

A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. [2008.08]

The efficacy of nebulized albuterol/ipratropium bromide versus albuterol alone in the prehospital treatment of suspected reactive airways disease. [2005.10]

more>>

Clinical Trials Related to Combivent (Ipratropium / Albuterol)

Respimat Combivent Trial in COPD [Completed]

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [Completed]

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients. [Completed]

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients. [Completed]

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) [Completed]

more>>